Stefan Ryser

Filings by Stefan Ryser span 2 companies, the busiest being Mabvax Therapeutics Holdings, Inc. and Achillion Pharmaceuticals Inc. Over a trading history stretching from 31 October 2006 to 15 May 2009, the count stands at 3 filings.

On the market, this insider has only sold: 2 sales, €2,845 in total. So far in 2009, the count stands at no purchases and 2 sales.

Most recently, on 18 May 2009, the filings show an open-market sale worth €933 in Mabvax Therapeutics Holdings, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.